We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FRAF:NASDAQFranklin Financial Services Corporation Analysis

Data as of 2026-06-09 - not real-time

$61.13

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Franklin Financial Services (FRAF) is trading at $61.13, comfortably above its 20‑day SMA of $57.34 and 50‑day SMA of $56.46, confirming a bullish price trend. The MACD line sits at 0.82 above its signal at 0.59, reinforcing momentum, while the RSI of 65 suggests the stock is approaching overbought territory but still within a healthy range. Valuation metrics are compelling: the forward P/E of 9.43 is well below the industry average of 16.55, and the DCF‑derived fair value of $160.40 indicates the market may be severely undervaluing the shares. Revenue growth of 22% and an operating margin of 37% highlight robust earnings potential, and a modest payout ratio of 24.7% supports the 2.31% dividend yield as sustainable. The low beta (~0.62) points to limited market sensitivity, yet 30‑day volatility of 36.8% signals price swings that could challenge short‑term traders. Investor sentiment is extremely bullish, as reflected by a Fear & Greed Index of 85.95 (Extreme Greed). Overall, the combination of strong fundamentals, attractive valuation, and supportive dividend policy makes FRAF a compelling buy for medium‑ and long‑term horizons, while short‑term participants may prefer a cautious hold given the elevated volatility and near‑overbought RSI.
The regional banking sector faces moderate regulatory scrutiny and interest‑rate headwinds, but FRAF’s diversified loan portfolio and low leverage (debt‑to‑equity effectively zero) mitigate many of those concerns. With cash reserves of $28.4 M and a market cap of $274.7 M, liquidity is adequate, though declining volume suggests a medium liquidity risk. Geographic exposure is limited to the United States, keeping currency risk low. Given these dynamics, the stock presents an attractive risk‑adjusted upside for investors willing to tolerate short‑term price swings.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 7/10

Key Factors

  • Price above 20‑day SMA indicating bullish trend
  • RSI at 65 signaling near‑overbought conditions
  • Decreasing volume and high 30‑day volatility

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Forward P/E of 9.43 vs industry average 16.55
  • Revenue growth of 22% and strong operating margin
  • Sustainable dividend with 24.7% payout ratio

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • DCF fair value of $160.40 implying >150% upside
  • Low beta (~0.62) indicating limited market risk
  • Diversified loan portfolio and minimal regulatory exposure

Key Metrics & Analysis

Financial Health

Revenue Growth22.00%
Profit Margin26.54%
P/E Ratio11.4
ROE14.50%
ROA1.05%
P/B Ratio1.5
Op. Cash Flow$40.7M
Industry P/E16.6

Technical Analysis

TrendBullish
RSI65.1
Support$54.30
Resistance$62.84
MA 20$57.34
MA 50$56.46
MA 200$51.07
MACDBullish
VolumeDecreasing
Fear & Greed Index85.95

Valuation

Fair Value$160.40
Target Price$64.00
Upside/Downside4.69%
GradeUndervalued
TypeBlend
Dividend Yield2.31%

Risk Assessment

Beta0.62
Volatility36.75%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.